Stock·NYSE·Healthcare
Novartis (NVS)
- Market cap
- $298.15B
- P/E
- 23.69
- Dividend yield
- 3.04%
- Street target
- $156.00median of 12 analysts
- 52-week range
- $121.57 $170.46
NVS stock forecast today
Where NVS stands today, and what CleaRank Financial AI makes of it.
NVS at a glance
Novartis (NVS): Buy, 69/100 on CleaRank's AI score.
- Trend Up: the price is above both its 50- and 200-day moving averages ($148.27 and $151.57).
- Earnings NVS beat estimates in 5 of the 7 reports in our data, yet fell the next day after 3 of those beats.
- Valuation P/E of 23.7 against 31.9 for the Healthcare sector: a discount to peers (-26%).
Figures as of October 27, 2026.
CleaRank Financial AI
NVS, the Novartis stock, earns a Buy rating from CleaRank with a model score of 69/100.
Momentum is the largest contributor: the 14-day RSI of 65.3 sits in the bullish zone and the MACD line is positive. Slower revenue growth holds the score back most, as revenue grew 0.80%, 7.3 percentage points slower than the sector median. The trend is up, with the price 5.80% above its 50-day average of $148.27 and 3.49% above its 200-day average of $151.57. The price has risen 21.47% over the past year.
Only on CleaRank
Figures we compute ourselves from NVS's own price, earnings and insider-filing history. Tap one to see it in context.
NVS stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
3/4Price above its 50-day average ›
The price of $156.86 is 5.8% above the 50-day simple moving average of $148.27.Price above its 200-day average ›
The price is 3.5% above the 200-day simple moving average of $151.57.50-day average above the 200-day ›
The 50-day average ($148.27) is 2.2% below the 200-day average ($151.57), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 72% of its 52-week range, between $121.57 and $170.46.
NVS share price
Pick a period: each tab shows how far NVS has moved over it, to the last close.
Today's trading
Where NVS sits inside today's range and its 52-week range.
NVS fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
4/5P/E below the sector median ›
The trailing P/E of 23.69 is 25.7% below the Healthcare median of 31.9.P/S below the sector median ›
The price-to-sales ratio of 5.26 is 54.7% above the sector median of 3.4.Profitable over the last 12 months ›
Net income over the last 12 months was $12.8B on revenue of $56.7B, a net margin of 22.5%.Beat estimates in most recent reports ›
NVS beat the EPS estimate in 5 of the 7 reports in our data.Pays a dividend ›
The trailing dividend yield is 3.04%, or $4.77 a share a year.
Key statistics
The headline figures for NVS.
As of October 27, 2026, NVS trades at $156.86, with a market value of $298.15B, a P/E ratio of 23.69 and a dividend yield of 3.04%.
What the numbers say
CleaRank Financial AI's reading of NVS's valuation, growth and risks.
NVS trades at a trailing P/E of 23.69, against a Healthcare median of 31.9. That places the P/E 25.7% below the sector median P/E, and the peer comparison on this page rates it as a discount to peers. On sales, the P/S of 5.26 sits 54.7% above the sector median of 3.4.
Year on year, revenue grew 0.80% in the latest quarter, leaving it 7.3 percentage points behind the Healthcare sector median of 8.1%. On profitability, the net margin stands at 22.50% and the operating margin at 34.62%. Return on equity is 30.35%, above the sector median of 7.3%. Debt-to-equity is 1.17, and the trailing dividend yield is 3.04%, or $4.77 a share a year.
NVS reported EPS of $2.41 in its most recent report, dated July 21, 2026, versus an estimate of $2.15. That was a beat of 12.09%. Even so, the share price dropped 0.51% in the next session.
Over the 7 reports in our data, NVS topped the estimate 5 times, but beats have not guaranteed gains: the stock fell the next day after 3 of them. Looking ahead, analysts expect EPS of $8.83 this fiscal year (a decline of 1.7%) and $9.80 the year after (growth of 11.0%).
NVS has a beta of 0.47 against the S&P 500, and the 30-day standard deviation of its daily returns is 1.36%.
NVS against the Healthcare sector
How NVS compares with the median Healthcare stock CleaRank tracks.
Price to earnings vs sector: NVS trades at a notable discount to sector peers (-26%), which may indicate undervaluation or specific company headwinds.
Return vs XLV: Since May 14, 2025, NVS has gained 46.5% against a gain of 39.2% for XLV.
Performance against XLV
NVS and the Healthcare sector fund over the same days.
Revenue and earnings
How much NVS sells, and how much of it becomes profit.
Revenue growth: Revenue grew 9.6% in FY2025 to $56.7B, from $51.7B a year earlier.
Profit margin: The net margin was 24.6% in FY2025, up from 23.1% the year before.
Profitable: NVS earned $14.0B in FY2025.
Earnings reality check
Did NVS beat what analysts expected, and how did the stock react?
Earnings record: NVS beat the analyst estimate in 5 of the 7 reports in our data.
Market reaction: The stock fell in the first session after 3 of those 5 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 21, 2026after close | $2.15 | $2.41 | +12.09% | -0.51% | +3.89% |
| Apr 28, 2026after close | $1.65 | $1.65 | +0.00% | -1.76% | +0.00% |
| Oct 28, 2025after close | $2.31 | $2.25 | -2.60% | -1.32% | +1.28% |
| Jul 17, 2025after close | $2.37 | $2.42 | +2.11% | -0.24% | +2.57% |
| Apr 29, 2025after close | $2.17 | $2.28 | +5.07% | +0.04% | -2.56% |
| Jan 31, 2025after close | $1.76 | $1.98 | +12.50% | +0.73% | +1.47% |
| Oct 29, 2024after close | $1.93 | $2.06 | +6.74% | -0.56% | -1.04% |
As of October 27, 2026, NVS has beaten the analyst EPS estimate in 5 of the 7 reports in our data and fell in the first trading session after 3 of those beats; its latest report, on July 21, 2026, came in 12.09% above the estimate and the stock moved -0.51% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
NVS AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
3/3RSI not overbought or oversold ›
The 14-day RSI is 65.3, showing bullish momentum without being overbought.RSI above 50 ›
An RSI of 65.3 is above the 50 midpoint, so buyers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is positive, so the 12-day average is above the 26-day average.
CleaRank Financial AI analysis of NVS
The score, the reasoning behind it, and what could move the price next.
NVS is in an uptrend: the price of $156.86 sits 3.49% above its 200-day average of $151.57 and 5.80% above its 50-day average of $148.27. The price is at 72% of its 52-week range, and 7.98% below the 52-week high of $170.46. Both averages still lag the price, with the 50-day 2.18% below the 200-day.
The 14-day RSI sits at 65.3, which is in the bullish zone without reaching overbought territory, and the MACD line is positive. Over the short and long run the picture diverges: the price rose 7.84% over the past month and 21.47% over the past year, but fell 1.87% over the past three months. In the last session the price rose 1.98%, with volume 64.5% above its average.
Analyst upgrade ›
HSBC upgraded it to Hold from Reduce on September 10, 2026.
Source: Analyst action, HSBC, September 10, 2026
Earnings beat, but the stock fell ›
The July 21, 2026 report beat the EPS estimate by 12.09%, and the share price fell 0.51% in the first session after it.
Source: Earnings report, July 21, 2026
- The two levels closest to the price are the 52-week high at $170.46, above it, and the 200-day SMA at $151.57, below it.
- A 14-day RSI of 65.3 is in the bullish zone, and the MACD line is positive. Readings above 70 or below 30 are where momentum starts to look stretched.
- The share price slipped 0.51% in the first session after the July 21, 2026 report. Over the 7 reports in our data, NVS has beaten estimates 5 times.
NVS trades above its 50-day and 200-day moving averages ($148.27 and $151.57), which is what makes the trend up; losing the 200-day would be the first warning. The nearest level under the price is the 200-day SMA at $151.57.
The next level overhead for NVS is the 52-week high at $170.46. The RSI is in the bullish band, supporting the current direction while sitting near the overbought threshold.
Technical indicators
Momentum and trend for NVS, from its daily closes.
As of October 27, 2026, with NVS at $156.86, its 14-day RSI is 65.3 (showing bullish momentum without being overbought), its 50-day simple moving average is $148.27 and its 200-day is $151.57.
Calculated by CleaRank on daily closes as of October 27, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What NVS moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 27, 2026, NVS's 1-year correlation of daily returns is +0.16 with S&P 500 (SPY), +0.03 with Nasdaq 100 (QQQ), +0.05 with Bitcoin (BTC) and +0.14 with gold (XAU).
NVS price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
0/3Most analysts rate it a buy ›
5 of 12 analysts rate it a buy or strong buy, 5 a hold and 2 a sell.Median target above the price ›
The median 12-month target of $156.00 is 0.5% below the price.More buy ratings than three months ago ›
5 of 12 rate it a buy now, against 5 of 12 three months ago.
NVS Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Sep 10, 2026 | HSBC | Upgrade | Hold |
As of October 27, 2026, 12 Wall Street analysts cover NVS: 5 rate it a buy or strong buy, 5 a hold and 2 a sell or strong sell. Their 12-month price targets range from $130.00 to $185.00. The median NVS price target is $156.00, 0.5% below the price of $156.86.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
NVS trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
NVS trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Long entry pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from NVS's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much NVS tends to move, against the market and on its own.
NVS price history and drawdowns
NVS's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
3/4Average daily move under 2% ›
The price has moved 1.36% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 21.8%, from February 2020 to March 2020, regained by December 2020.Most 1-year holds ended higher ›
83% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $33,982, against $42,015 in the S&P 500 (SPY).
NVS Drawdowns & Recovery
As of October 27, 2026, NVS's worst peak-to-trough fall over the last 10 years with dividends reinvested was -21.8% (February 2020 to March 2020); it regained that peak by December 2020, 9 months after the low, and 83% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into NVS in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: NVS trailed the S&P 500 over this period: $33,982 against $42,015.
A $10,000 investment in NVS in October 2016 would be worth about $33,982 today with dividends reinvested, compared with about $42,015 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to NVS, and which have not.
Strongest month, November: an average of +2.59%, up in 7 of 10 years.
Weakest month, September: an average of -2.43%, up in 4 of 10 years.
This month, October: has averaged -1.59%, up in 4 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, NVS's strongest calendar month has been November (average +2.59%, up in 7 of 10 years) and its weakest September (average -2.43%, up in 4 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
NVS stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in NVS, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in NVS today could grow to about $13,325 by 2030 in the base case, with a 90th-percentile outcome near $22,510 and a 10th-percentile outcome around $7,888. The simulation models price only; at today's 3.04% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
NVS Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $209 for NVS by 2030 in the base case, from $157 today (1.3x over 4 years). The 10th-percentile path ends near $124. These are outcomes of a Monte Carlo simulation run on NVS's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $130 | $169 | $219 | |
| 2028 | $125 | $181 | $262 | |
| 2029 | $124 | $195 | $306 | |
| 2030 | $124 | $209 | $353 |
Method: a lognormal simulation of NVS's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. How the simulation works
NVS stock forecast: questions people ask
Answered from the figures on this page, as of October 27, 2026.